packageTrastuzumab

trastuzumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Trastuzumab is a monoclonal antibody used to treat HER2-positive cancers, mainly breast cancer and gastric cancer. It is widely used and authorised in the European Union, and is included on the WHO list of essential medicines.

Summary written by glm-5.3-flash from Wikidata Q412616 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:trastuzumab
ATC codes:L01FD01, L01XC03
DrugBank:DB00072
Wikidata:Q412616
molar mass:145532 g/mol (Drugs.Common 25.09, not verified)

Metabolites

MMAEMMAE717.993 g/mol (pubchem)
Rezetecanrezetecanmolar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
MMAEmetabolite: MMAE
Rezetecanmetabolite: rezetecan